Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine
https://investors.amyris.com/2020-10-22-Amyris-and-The-Infectious-Disease-Research-Institute-Enter-into-Exclusive-License-for-Novel-RNA-Vaccine-Platform-Beginning-with-COVID-19-Vaccine
© 2022 Regents of the University of California. All Rights Reserved.